The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Considerations for the Use of Phage Therapy in Clinical Practice
Open accessAbstract
Increasing antimicrobial resistance and medical device-related infections have led to a renewed interest in phage therapy as an alternative or adjunct to conventional antimicrobials. Expanded access and compassionate use cases have risen exponentially but have varied widely in approach, methodology, clinical situations in which phage therapy might be considered, dosing, route of administration, and outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., Russell, D. A., Ford, K., Harris, K., Gilmour, K. C., Soothill, J., Jacobs-Sera, D., Schooley, R. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0437-z · Cited by 1,410
Mackay, I. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.6.1292 · Cited by 1,318
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Jault, P., Leclerc, T., Jennes, S., Pirnay, J. P., Que, Y.-A., Resch, G., Rousseau, A. F., Ravat, F., Carsin, H., Le Floch, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30482-1 · Cited by 874
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
Self-citationGarneau, J. R., Depardieu, F., Fortier, L.-C., Bikard, D., & Monot, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-07910-5 · Cited by 685
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy
Bruttin, A., & Brüssow, H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2874-2878.2005 · Cited by 563
Phage Host Range and Efficiency of Plating
Kutter, E. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-164-6_14 · Cited by 558
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa
Chan, B. K., Turner, P. E., Kim, S., Mojibian, H. R., Elefteriades, J. A., & Narayan, D. (2018) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoy005 · Cited by 501
Self-citationA new perspective on lysogeny: prophages as active regulatory switches of bacteria
Feiner, R., Argov, T., Rabinovich, L., Sigal, N., Borovok, I., & Herskovits, A. A. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3527 · Cited by 488
Roach, D. R., Leung, C. Y., Henry, M., Morello, E., Singh, D., Di Santo, J. P., Weitz, J. S., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.018 · Cited by 484
Safety of bacteriophage therapy in severe Staphylococcus aureus infection
Petrovic Fabijan, A., Lin, R. C. Y., Ho, J., Maddocks, S., Ben Zakour, N. L., Iredell, J. R., Westmead Bacteriophage Therapy Team, Khalid, A., Venturini, C., Chard, R., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0634-z · Cited by 471
Pre-PCR Processing : Strategies to Generate PCR-Compatible Samples
Rådström, P., Knutsson, R., Wolffs, P., Lövenklev, M., & Löfström, C. (2004) · Molecular Biotechnology · doi:10.1385/mb:26:2:133 · Cited by 452
Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.1.13980 · Cited by 410
Gu Liu, C., Green, S. I., Min, L., Clark, J. R., Salazar, K. C., Terwilliger, A. L., Kaplan, H. B., Trautner, B. W., Ramig, R. F., & Maresso, A. W. (2020) · mBio · doi:10.1128/mbio.01462-20 · Cited by 409
Self-citationInteractions between Bacteriophage, Bacteria, and the Mammalian Immune System
Van Belleghem, J. D., Dąbrowska, K., Vaneechoutte, M., Barr, J. J., & Bollyky, P. L. (2018) · Viruses · doi:10.3390/v11010010 · Cited by 408
Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
Chaudhry, W. N., Concepción-Acevedo, J., Park, T., Andleeb, S., Bull, J. J., & Levin, B. R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0168615 · Cited by 394
Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers
Nguyen, S., Baker, K., Padman, B. S., Patwa, R., Dunstan, R. A., Weston, T. A., Schlosser, K., Bailey, B., Lithgow, T., Lazarou, M., et al. (2017) · mBio · doi:10.1128/mbio.01874-17 · Cited by 378
Dąbrowska, K. (2019) · Medicinal Research Reviews · doi:10.1002/med.21572 · Cited by 375
More Is Better: Selecting for Broad Host Range Bacteriophages
Ross, A., Ward, S., & Hyman, P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01352 · Cited by 367
Conceição-Neto, N., Zeller, M., Lefrère, H., De Bruyn, P., Beller, L., Deboutte, W., Yinda, C. K., Lavigne, R., Maes, P., Ranst, M. V., et al. (2015) · Scientific Reports · doi:10.1038/srep16532 · Cited by 363
Pirnay, J.-P., Verbeken, G., Ceyssens, P.-J., Huys, I., De Vos, D., Ameloot, C., & Fauconnier, A. (2018) · Viruses · doi:10.3390/v10020064 · Cited by 347
Preventing biofilms of clinically relevant organisms using bacteriophage
Donlan, R. M. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.11.002 · Cited by 345
Aslam, S., Lampley, E., Wooten, D., Karris, M., Benson, C., Strathdee, S., & Schooley, R. T. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa389 · Cited by 342
Self-citationOechslin, F., Piccardi, P., Mancini, S., Gabard, J., Moreillon, P., Entenza, J. M., Resch, G., & Que, Y.-A. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw632 · Cited by 325
Leitner, L., Ujmajuridze, A., Chanishvili, N., Goderdzishvili, M., Chkonia, I., Rigvava, S., Chkhotua, A., Changashvili, G., McCallin, S., Schneider, M. P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30330-3 · Cited by 322
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
Hodyra-Stefaniak, K., Miernikiewicz, P., Drapała, J., Drab, M., Jończyk-Matysiak, E., Lecion, D., Kaźmierczak, Z., Beta, W., Majewska, J., Harhala, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14802 · Cited by 302
Early clinical experience of bacteriophage therapy in 3 lung transplant recipients
Aslam, S., Courtwright, A. M., Koval, C., Lehman, S. M., Morales, S., Furr, C.-L. L., Rosas, F., Brownstein, M. J., Fackler, J. R., Sisson, B. M., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15503 · Cited by 285
Self-citationAbedon, S., & Thomas-Abedon, C. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725410 · Cited by 284
Wiggins, B. A., & Alexander, M. (1985) · Applied and Environmental Microbiology · doi:10.1128/aem.49.1.19-23.1985 · Cited by 275
Standardized bacteriophage purification for personalized phage therapy
Luong, T., Salabarria, A.-C., Edwards, R. A., & Roach, D. R. (2020) · Nature Protocols · doi:10.1038/s41596-020-0346-0 · Cited by 274
PHACTS, a computational approach to classifying the lifestyle of phages
McNair, K., Bailey, B. A., & Edwards, R. A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts014 · Cited by 269
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies
Liu, D., Van Belleghem, J. D., de Vries, C. R., Burgener, E., Chen, Q., Manasherob, R., Aronson, J. R., Amanatullah, D. F., Tamma, P. D., & Suh, G. A. (2021) · Viruses · doi:10.3390/v13071268 · Cited by 268
Self-citationPhage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong, T., Salabarria, A.-C., & Roach, D. R. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.07.014 · Cited by 266
Dynamic biofilm architecture confers individual and collective mechanisms of viral protection
Vidakovic, L., Singh, P. K., Hartmann, R., Nadell, C. D., & Drescher, K. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0050-1 · Cited by 265
Nir-Paz, R., Gelman, D., Khouri, A., Sisson, B. M., Fackler, J., Alkalay-Oren, S., Khalifa, L., Rimon, A., Yerushalmy, O., Bader, R., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz222 · Cited by 265
Law, N., Logan, C., Yung, G., Furr, C.-L. L., Lehman, S. M., Morales, S., Rosas, F., Gaidamaka, A., Bilinsky, I., Grint, P., et al. (2019) · Infection · doi:10.1007/s15010-019-01319-0 · Cited by 260
Self-citationPhage therapy experience at the Eliava Institute
Kutateladze, M., & Adamia, R. (2008) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2008.06.023 · Cited by 258
Transdermal protein delivery by a coadministered peptide identified via phage display
Chen, Y., Shen, Y., Guo, X., Zhang, C., Yang, W., Ma, M., Liu, S., Zhang, M., & Wen, L.-P. (2006) · Nature Biotechnology · doi:10.1038/nbt1193 · Cited by 249
Jennes, S., Merabishvili, M., Soentjens, P., Pang, K. W., Rose, T., Keersebilck, E., Soete, O., François, P.-M., Teodorescu, S., Verween, G., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1709-y · Cited by 248
Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
LaVergne, S., Hamilton, T., Biswas, B., Kumaraswamy, M., Schooley, R. T., & Wooten, D. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy064 · Cited by 239
Kamal, F., & Dennis, J. J. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.02850-14 · Cited by 224
Overcoming the Phage Replication Threshold: a Mathematical Model with Implications for Phage Therapy
Kasman, L. M., Kasman, A., Westwater, C., Dolan, J., Schmidt, M. G., & Norris, J. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5557-5564.2002 · Cited by 221
Phage Neutralization by Sera of Patients Receiving Phage Therapy
Łusiak-Szelachowska, M., Żaczek, M., Weber-Dąbrowska, B., Międzybrodzki, R., Kłak, M., Fortuna, W., Letkiewicz, S., Rogóż, P., Szufnarowski, K., Jończyk-Matysiak, E., et al. (2014) · Viral Immunology · doi:10.1089/vim.2013.0128 · Cited by 218
Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals
Payne, R. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109520 · Cited by 216
Dąbrowska, K., & Abedon, S. T. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-19 · Cited by 212
Chhibber, S., Kaur, T., & Kaur, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056022 · Cited by 204
Phage therapy dosing: The problem(s) with multiplicity of infection (MOI)
Abedon, S. T. (2016) · Bacteriophage · doi:10.1080/21597081.2016.1220348 · Cited by 201
Dedrick, R. M., Freeman, K. G., Nguyen, J. A., Bahadirli-Talbott, A., Smith, B. E., Wu, A. E., Ong, A. S., Lin, C. T., Ruppel, L. C., Parrish, N. M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01403-9 · Cited by 200
Bacteriophage Therapy of Bacterial Infections: An Update of our Institute’s Experience
Weber-Dąbrowska, B., Mulczyk, M., & Górski, A. (2001) · Inflammation · doi:10.1007/978-94-015-9702-9_15 · Cited by 199
Fate of Bacteriophage Lambda in Non-immune Germ-free Mice
GEIER, M. R., TRIGG, M. E., & MERRIL, C. R. (1973) · Nature · doi:10.1038/246221a0 · Cited by 191
The disparate effects of bacteriophages on antibiotic-resistant bacteria
Torres-Barceló, C. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0169-z · Cited by 189
Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood
Majewska, J., Beta, W., Lecion, D., Hodyra-Stefaniak, K., Kłopot, A., Kaźmierczak, Z., Miernikiewicz, P., Piotrowicz, A., Ciekot, J., Owczarek, B., et al. (2015) · Viruses · doi:10.3390/v7082845 · Cited by 186
El Haddad, L., Harb, C. P., Gebara, M. A., Stibich, M. A., & Chemaly, R. F. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy947 · Cited by 185
Hawkins, C., Harper, D., Burch, D., Änggård, E., & Soothill, J. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.05.014 · Cited by 183
Characterizing Phage Genomes for Therapeutic Applications
Philipson, C., Voegtly, L., Lueder, M., Long, K., Rice, G., Frey, K., Biswas, B., Cer, R., Hamilton, T., & Bishop-Lilly, K. (2018) · Viruses · doi:10.3390/v10040188 · Cited by 183
Bao, J., Wu, N., Zeng, Y., Chen, L., Li, L., Yang, L., Zhang, Y., Guo, M., Li, L., Li, J., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1747950 · Cited by 182
Ooi, M. L., Drilling, A. J., Morales, S., Fong, S., Moraitis, S., Macias-Valle, L., Vreugde, S., Psaltis, A. J., & Wormald, P.-J. (2019) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2019.1191 · Cited by 181
Anderson, B., Rashid, M. H., Carter, C., Pasternack, G., Rajanna, C., Revazishvili, T., Dean, T., Senecal, A., & Sulakvelidze, A. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15456 · Cited by 180
Tkhilaishvili, T., Winkler, T., Müller, M., Perka, C., & Trampuž, A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00924-19 · Cited by 179
Bacteriophages and the Immune System
Popescu, M., Van Belleghem, J. D., Khosravi, A., & Bollyky, P. L. (2021) · Annual Review of Virology · doi:10.1146/annurev-virology-091919-074551 · Cited by 178 · cited 1×
“Although bacteria are the designated hosts of phages, a complex interplay between the human (superhost) immune system, phages, and bacteria likely impacts phage activity and potentially larger aspects of human health and disease (128, 129).”
BackgroundWu, N., Dai, J., Guo, M., Li, J., Zhou, X., Li, F., Gao, Y., Qu, H., Lu, H., Jin, J., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1902754 · Cited by 178
Bacteriophage Therapy in Implant-Related Infections: An Experimental Study
Yilmaz, C., Colak, M., Yilmaz, B. C., Ersoz, G., Kutateladze, M., & Gozlugol, M. (2013) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/jbjs.k.01135 · Cited by 174
The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside
Meštrović, T., Matijašić, M., Perić, M., Paljetak, H. Č., Barešić, A., & Verbanac, D. (2020) · Diagnostics · doi:10.3390/diagnostics11010007 · Cited by 173
Akturk, E., Oliveira, H., Santos, S. B., Costa, S., Kuyumcu, S., Melo, L. D. R., & Azeredo, J. (2019) · Antibiotics · doi:10.3390/antibiotics8030103 · Cited by 172
Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery
Rubalskii, E., Ruemke, S., Salmoukas, C., Boyle, E. C., Warnecke, G., Tudorache, I., Shrestha, M. L., Schmitto, J. D., Martens, A., Rojas, S. V., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9050232 · Cited by 172
Corbellino, M., Kieffer, N., Kutateladze, M., Balarjishvili, N., Leshkasheli, L., Askilashvili, L., Tsertsvadze, G., Rimoldi, S. G., Nizharadze, D., Hoyle, N., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz782 · Cited by 169
Synergy as a rationale for phage therapy using phage cocktails
Schmerer, M. W., Molineux, I. J., & Bull, J. J. (2014) · PeerJ · doi:10.7717/peerj.590 · Cited by 166
Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics
Cooper, C. J., Khan Mirzaei, M., & Nilsson, A. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01209 · Cited by 165
Adapted Bacteriophages for Treating Urinary Tract Infections
Ujmajuridze, A., Chanishvili, N., Goderdzishvili, M., Leitner, L., Mehnert, U., Chkhotua, A., Kessler, T. M., & Sybesma, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01832 · Cited by 163
Phage Therapy Regulation: From Night to Dawn
Fauconnier, A. (2019) · Viruses · doi:10.3390/v11040352 · Cited by 162
Jikia, D., Chkhaidze, N., Imedashvili, E., Mgaloblishvili, I., Tsitlanadze, G., Katsarava, R. D., Morris, J. G., & Sulakvelidze, A. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2004.01600.x · Cited by 160
Onsea, J., Soentjens, P., Djebara, S., Merabishvili, M., Depypere, M., Spriet, I., De Munter, P., Debaveye, Y., Nijs, S., Vanderschot, P., et al. (2019) · Viruses · doi:10.3390/v11100891 · Cited by 160
Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa
Knezevic, P., Curcin, S., Aleksic, V., Petrusic, M., & Vlaski, L. (2013) · Research in Microbiology · doi:10.1016/j.resmic.2012.08.008 · Cited by 159
Kumaran, D., Taha, M., Yi, Q., Ramírez‐Arcos, S., Diallo, J., Carli, A. V., & Abdelbary, H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00127 · Cited by 157
Cobb, L. H., Park, J., Swanson, E. A., Beard, M. C., McCabe, E. M., Rourke-Funderburg, A. S., Seo, K. S., Olivier, A. K., & Priddy, L. B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220421 · Cited by 155
Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model
Nath, G., Kishor, C., Mishra, R., Saraf, S., Kumar, M., & Srivastav, A. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.178615 · Cited by 151
Kumari, S., Harjai, K., & Chhibber, S. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.018580-0 · Cited by 149
Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy
Duplessis, C. A., Biswas, B., Hanisch, B. R., Perkins, M., Henry, M. S., Quinones, J., Wolfe, D., Estrella, L. A., & Hamilton, T. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix056 · Cited by 148
Hoyle, N. S., Zhvania, P., Balarjishvili, N., Bolkvadze, D., Nadareishvili, L., Nizharadze, D., Wittmann, J., Rohde, C., & Kutateladze, M. (2018) · Research in Microbiology · doi:10.1016/j.resmic.2018.05.001 · Cited by 145
Bacteriophage Enumeration and Detection Methods
Ács, N., Gambino, M., & Brøndsted, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.594868 · Cited by 139
Pharmacological limitations of phage therapy
Nilsson, A. S. (2019) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2019.1688433 · Cited by 138
Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
Bretaudeau, L., Tremblais, K., Aubrit, F., Meichenin, M., & Arnaud, I. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01161 · Cited by 137
Removal of Endotoxins from Bacteriophage Preparations by Extraction with Organic Solvents
Szermer-Olearnik, B., & Boratyński, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122672 · Cited by 136
Abedon, S. T. (2011) · Advances in applied microbiology · doi:10.1016/b978-0-12-387044-5.00001-7 · Cited by 135
Bacteriophage Electron Microscopy
Ackermann, H.-W. (2012) · Advances in virus research · doi:10.1016/b978-0-12-394621-8.00017-0 · Cited by 134
Żaczek, M., Łusiak-Szelachowska, M., Jończyk‐Matysiak, E., Weber‐Dąbrowska, B., Międzybrodzki, R., Owczarek, B., Kopciuch, A., Fortuna, W., Rogóż, P., & Górski, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01681 · Cited by 134
The Removal of Endo- and Enterotoxins From Bacteriophage Preparations
Hietala, V., Horsma‐Heikkinen, J., Carron, A., Skurnik, M., & Kiljunen, S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01674 · Cited by 134
Cerca, N., de Oliveira, R. P. S., & Azeredo, J. (2007) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2007.02190.x · Cited by 133
Bacteriophage therapy: a regulatory perspective
Pelfrene, E., Willebrand, E., Sanches, A., Sebris, Z., & Cavaleri, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw083 · Cited by 133
Coulter, L. B., McLean, R. J. C., Rohde, R. E., & Aron, G. M. (2014) · Viruses · doi:10.3390/v6103778 · Cited by 129
Applications of Bacteriophages in the Treatment of Localized Infections in Humans
Morozova, V. V., Vlassov, V. V., & Викторовна, Т. Н. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01696 · Cited by 126
Jansen, M., Wahida, A., Latz, S., Krüttgen, A., Häfner, H., Buhl, E. M., Ritter, K., & Horz, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-32344-y · Cited by 121
Kirby, A. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051017 · Cited by 120
A double layer plaque assay using spread plate technique for enumeration of bacteriophage MS2
Cormier, J., & Janes, M. E. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.10.034 · Cited by 120
Chang, R., Das, T., Manos, J., Kutter, E., Morales, S., & Chan, H. (2019) · AAPS Journal · doi:10.1208/s12248-019-0315-0 · Cited by 118
Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration
Fukuda, K., Ishida, W., Uchiyama, J., Rashel, M., Kato, S.-I., Morita, T., Muraoka, A., Sumi, T., Matsuzaki, S., Daibata, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047742 · Cited by 116
T4 phages against Escherichia coli diarrhea: Potential and problems
Denou, E., Bruttin, A., Barretto, C., Ngom‐Bru, C., Brüssow, H., & Zuber, S. (2009) · Virology · doi:10.1016/j.virol.2009.03.009 · Cited by 112
Constructing and Characterizing Bacteriophage Libraries for Phage Therapy of Human Infections
Gibson, S., Green, S. I., Liu, C. G., Salazar, K. C., Clark, J. R., Terwilliger, A. L., Kaplan, H. B., Maresso, A. W., Trautner, B. W., & Ramig, R. F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02537 · Cited by 110
Self-citationPhage Therapy: The Pharmacology of Antibacterial Viruses
Danis-Wlodarczyk, K. M., Dąbrowska, K., & Abedon, S. T. (2020) · Current Issues in Molecular Biology · doi:10.21775/cimb.040.081 · Cited by 105
Carrigy, N. B., Chang, R. Y. K., Leung, S. S. Y., Harrison, M., Petrova, Z. O., Pope, W. H., Hatfull, G. F., Britton, W. J., Chan, H., Sauvageau, D., et al. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2213-4 · Cited by 103
Therapeutics and delivery vehicles for local treatment of osteomyelitis
Cobb, L. H., McCabe, E. M., & Priddy, L. B. (2020) · Journal of Orthopaedic Research® · doi:10.1002/jor.24689 · Cited by 103
Vieira, A., Silva, Y. J., Cunha, Â., Gomes, N. C. M., Ackermann, H.-W., & Almeida, A. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1691-x · Cited by 102
Majewska, J., Kaźmierczak, Z., Lahutta, K., Lecion, D., Szymczak, A., Miernikiewicz, P., Drapała, J., Harhala, M. A., Marek-Bukowiec, K., Jędruchniewicz, N., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02607 · Cited by 101
Ferry, T., Boucher, F., Fèvre, C., Perpoint, T., Château, J., Petitjean, C., Josse, J., Chidiac, C., L’Hostis, G., Leboucher, G., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky263 · Cited by 100
Local Bacteriophage Delivery for Treatment and Prevention of Bacterial Infections
Rotman, S. G., Sumrall, E. T., Ziadlou, R., Grijpma, D. W., Richards, R. G., Eglin, D., & Moriarty, T. F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.538060 · Cited by 100
Preparation of endotoxin-free bacteriophages.
Boratyński, J., Syper, D., Weber‐Dąbrowska, B., Łusiak-Szelachowska, M., Poźniak, G., & Górski, A. (2004) · PubMed · Cited by 99
Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child
Khatami, A., Lin, R. C. Y., Fabijan, A. P., Alkalay‐Oren, S., Almuzam, S., Britton, P. N., Brownstein, M., Dao, Q., Fackler, J., Hazan, R., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202113936 · Cited by 96
Fast phage detection and quantification: An optical density-based approach
Rajnovic, D., Muñoz‐Berbel, X., & Mas, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216292 · Cited by 94
Fish, R., Kutter, E. M., Wheat, G., Blasdel, B. G., Kutateladze, M., & Kuhl, S. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7395-8_14 · Cited by 91
Bacteriophage exploitation of bacterial biofilms: phage preference for less mature targets?
Abedon, S. T. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv246 · Cited by 89
Gelman, D., Beyth, S., Lerer, V., Adler, K. D., Cohen‐Poradosu, R., Coppenhagen‐Glazer, S., & Hazan, R. (2018) · Research in Microbiology · doi:10.1016/j.resmic.2018.04.008 · Cited by 87
Milo, S., Hathaway, H. J., Nzakizwanayo, J., Alves, D. R., Esteban, P. P., Jones, B. V., & Jenkins, A. T. A. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01302g · Cited by 85
Ferry, T., Batailler, C., Petitjean, C., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00342 · Cited by 82
Golshahi, L., Seed, K. D., Dennis, J. J., & Finlay, W. H. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0701 · Cited by 78
Aggregation/dispersion transitions of T4 phage triggered by environmental ion availability
Szermer-Olearnik, B., Dráb, M., Mąkosa, M., Zembala, M., Barbasz, J., Dąbrowska, K., & Boratyński, J. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0266-5 · Cited by 75
Duplessis, C. A., & Biswas, B. (2020) · Antibiotics · doi:10.3390/antibiotics9070377 · Cited by 75
Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract
Green, S. I., Liu, C. G., Yu, X. Q., Gibson, S., Salmen, W., Rajan, A., Carter, H. E., Clark, J. R., Song, X., Ramig, R. F., et al. (2021) · mBio · doi:10.1128/mbio.03474-20 · Cited by 75
Self-citationAdsorption of bacteriophages on polypropylene labware affects the reproducibility of phage research
Richter, Ł., Księżarczyk, K., Paszkowska, K., Janczuk-Richter, M., Niedziółka‐Jönsson, J., Gapiński, J., Łoś, M., Hołyst, R., & Paczesny, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-86571-x · Cited by 72
Bacteriophage therapy for infections in CF
Chan, B. K., Stanley, G., Modak, M., Koff, J. L., & Turner, P. E. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25190 · Cited by 70
Self-citationLiao, K. S., Lehman, S. M., Tweardy, D. J., Donlan, R. M., & Trautner, B. W. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05432.x · Cited by 69
Międzybrodzki, R., Fortuna, W., Weber‐Dąbrowska, B., & Górski, A. (2009) · Clinical and Experimental Medicine · doi:10.1007/s10238-009-0044-2 · Cited by 67
Kumari, S., Harjai, K., & Chhibber, S. (2010) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.312 · Cited by 66
Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin
Shlezinger, M., Coppenhagen‐Glazer, S., Gelman, D., Beyth, N., & Hazan, R. (2019) · Viruses · doi:10.3390/v11100954 · Cited by 66
Perspectives of Phage Therapy in Non-bacterial Infections
Górski, A., Bollyky, P. L., Przybylski, M., Borysowski, J., Międzybrodzki, R., Jończyk‐Matysiak, E., & Weber‐Dąbrowska, B. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03306 · Cited by 62
Nadithe, V., Rahamatalla, M., Finlay, W. H., Mercer, J. R., & Samuel, J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10379 · Cited by 57
Johri, A. V., Johri, P., Hoyle, N. S., Pipia, L., Nadareishvili, L., & Nizharadze, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.692614 · Cited by 57
Barceló, C. T., Franzon, B., Vasse, M., & Hochberg, M. (2016) · Evolutionary Applications · doi:10.1111/eva.12364 · Cited by 55
Alfadhel, M. M., Puapermpoonsiri, U., Ford, S. J., McInnes, F. J., & van der Walle, C. F. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.006 · Cited by 52
Salazar, K. C., Ma, L. M., Green, S. I., Zulk, J. J., Trautner, B. W., Ramig, R. F., Clark, J. R., Terwilliger, A. L., & Maresso, A. W. (2021) · mBio · doi:10.1128/mbio.00211-21 · Cited by 51
Self-citationRouse, M. D., Stanbro, J., Roman, J. A., Lipinski, M. A., Jacobs, A. C., Biswas, B., Regeimbal, J. M., Henry, M., Stockelman, M. G., & Simons, M. P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00414 · Cited by 46
Microneedle-mediated transdermal bacteriophage delivery
Ryan, E. M., Garland, M. J., Singh, T. R. R., Bambury, E., O’Dea, J., Migalska, K., Gorman, S. P., McCarthy, H. O., Gilmore, B., & Donnelly, R. F. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.06.012 · Cited by 45
Rastogi, V., Yadav, P., Verma, A. K., & Pandit, J. K. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.07.014 · Cited by 44
Bacteriophage-based tools: recent advances and novel applications
O’Sullivan, L., Buttimer, C., McAuliffe, O. E., Bolton, D., & Coffey, A. (2016) · F1000Research · doi:10.12688/f1000research.9705.1 · Cited by 43
Morrisette, T., Lev, K. L., Kebriaei, R., Abdul‐Mutakabbir, J. C., Stamper, K. C., Morales, S., Lehman, S. M., Canfield, G. S., Duerkop, B. A., Arias, C. A., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00993-20 · Cited by 35
Self-citationMycovirus therapy for invasive pulmonary aspergillosis?
van de Sande, W. W. J., & Vonk, A. G. (2018) · Medical Mycology · doi:10.1093/mmy/myy073 · Cited by 33
Freyberger, H. R., He, Y., Roth, A. L., Nikolich, M. P., & Filippov, A. A. (2018) · Viruses · doi:10.3390/v10110617 · Cited by 28
Modification ofEscherichia coli–bacteriophage interactions by surfactants and antibioticsin vitro
Scanlan, P. D., Bischofberger, A. M., & Hall, A. R. (2016) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiw211 · Cited by 25
Real-Time qPCR as a Method for Detection of Antibody-Neutralized Phage Particles
Kłopot, A., Zakrzewska, A., Lecion, D., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02170 · Cited by 22
Bernasconi, O. J., Donà, V., Tinguely, R., & Endimiani, A. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.12.013 · Cited by 21
Caflisch, K. M., & Patel, R. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00229-19 · Cited by 21
Self-citationBacteriophage therapy as a treatment option for transplant infections
Aslam, S. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000658 · Cited by 19
Self-citationGuerin, K. I., Choi, V. W., Aranda, J., et al. (2015) · Molecular Therapy · doi:10.1016/s1525-0016(16)34214-9 · Cited by 5
Cited by
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Phage therapy: From biological mechanisms to future directions
Strathdee, S. A., Hatfull, G. F., Mutalik, V. K., & Schooley, R. T. (2023) · Cell · doi:10.1016/j.cell.2022.11.017 · Cited by 817
Pirnay, J.-P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., Green, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01705-x · Cited by 474
Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Linz, M. S., Mattappallil, A., Finkel, D., & Parker, D. (2023) · Antibiotics · doi:10.3390/antibiotics12030557 · Cited by 293
The applications of animal models in phage therapy: An update
Mehmood Khan, F., Manohar, P., Singh Gondil, V., Mehra, N., Kayode Oyejobi, G., Odiwuor, N., Ahmad, T., & Huang, G. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2175519 · Cited by 32
Metadata
- Authors
- Suh, G. A., Lodise, T. P., Tamma, P. D., Knisely, J. M., Alexander, J., Aslam, S., Barton, K. D., Bizzell, E., Totten, K. M. C., Campbell, J. L., Chan, B. K., Cunningham, S. A., Goodman, K. E., Greenwood-Quaintance, K. E., Harris, A. D., Hesse, S., Maresso, A., Nussenblatt, V., Pride, D., Rybak, M. J., Sund, Z., van Duin, D., Van Tyne, D., Patel, R., & for the Antibacterial Resistance Leadership Group
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2022-03-15
- Volume
- 66
- Issue
- 3
- Pages
- e0207121-e0207121
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W4205772264
- Cited by
- 378
- References
- 146
- FWCI
- 37.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.